The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies

被引:9
|
作者
Wan, Xiaohua [1 ]
Wen, Jiangping [1 ]
Song, Xin [1 ]
Guo, Yongjun [1 ]
Liu, Xiangyi [1 ]
Yang, Benshan [1 ]
Lu, Xinxin [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Clin Lab, Beijing 100730, Peoples R China
关键词
Second-trimester; triple screening; Down syndrome; alpha fetoprotein; human chorionic gonadotropin; unconjugated estriol; HUMAN CHORIONIC-GONADOTROPIN; SERUM ALPHA-FETOPROTEIN; MATERNAL SERUM; TECHNICAL STANDARDS; WEIGHT-CORRECTION; GUIDELINES; ANALYZER; MEDIANS; MARKERS;
D O I
10.3109/00365513.2012.729858
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and objectives. The study aimed to compare the a fetoprotein (AFP), total beta-human chorionic gonadotropin (hCG), and unconjugated estriol (uE3) levels in the second-trimester triple screening for Down syndrome with different regions, and to analyse the related factors that influenced the screening performance. Materials and methods. The study was conducted between February 2007 and November 2010 in Beijing Tongren Hospital, P. R. China. Data derived from 7,647 normal singleton pregnancies between 14 and 21 weeks of gestation were examined. The regressed median values in different gestational ages were compared with earlier published data from other regions. The distribution of median values and multiples of median (MoM) of AFP, hCG and uE3 according to maternal age and weight in normal pregnancies were described. Statistic parameters for AFP, hCG, and uE3 (based on log(10) MoM values) were compared with earlier published data from other studies. Results. There were significantly increasing trends for AFP (p < 0.001) and uE3 (p < 0.001), and a significantly decreasing trend for hCG (p < 0.001) in the second trimester. There were significantly decreasing trends with increasing maternal weight for all the markers and their MoMs (p < 0.001). The distribution of the log(10) MoM marker values were Gaussian for the three parameters. Conclusions. Ethnic and laboratory variance should be taken into account in the second trimester triple screening for Down syndrome. The parameters of maternal serum markers should be calculated using local data, and the algorithm modified to match the screening achievable for the local population.
引用
收藏
页码:642 / 647
页数:6
相关论文
共 50 条
  • [31] Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population
    Xie, Zhenwei
    Lu, Shiming
    Li, Hui
    PRENATAL DIAGNOSIS, 2010, 30 (01) : 74 - 76
  • [32] Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome
    Muller, F
    Dreux, S
    Lemeur, A
    Sault, C
    Desgrès, J
    Bernard, MA
    Giorgetti, C
    Lemay, C
    Mirallié, S
    Beauchet, A
    PRENATAL DIAGNOSIS, 2003, 23 (13) : 1073 - 1076
  • [33] Second-trimester maternal serum invasive trophoblast antigen: A marker for down syndrome screening
    Pandian, R
    Cole, LA
    Palomaki, GE
    CLINICAL CHEMISTRY, 2004, 50 (08) : 1433 - 1435
  • [34] Interference in the autoDELFIA® hAFP immunoassay and effect on second-trimester Down's syndrome screening
    Taylor, Kevin P.
    Goodburn, Sandy
    Halsall, David J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 : 412 - 413
  • [35] Combined first- and second-trimester screening for Down syndrome: an evaluation of proMBP as a marker
    Rode, L
    Wojdemann, KR
    Shalmi, AC
    Larsen, SO
    Sundberg, K
    Norgaard-Pedersen, B
    Christiansen, M
    Tabor, A
    PRENATAL DIAGNOSIS, 2003, 23 (07) : 593 - 598
  • [36] First- and second-trimester screening - Detection of aneuploidies other than down syndrome
    Breathnach, Fionnuala M.
    Malone, Fergal D.
    Lambert-Messerlian, Geralyn
    Cuckle, Howard S.
    Porter, T. Flint
    Nyberg, David A.
    Comstock, Christine H.
    Saade, George R.
    Berkowitz, Richard L.
    Klugman, Susan
    Dugoff, Lorraine
    Craigo, Sabrina D.
    Timor-Tritsch, Ilan E.
    Carr, Stephen R.
    Wolfe, Honor M.
    Tripp, Tara
    Bianchi, Diana W.
    D'Alton, Mary E.
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (03): : 651 - 657
  • [37] Strict glycemic control in diabetic pregnancy - implications for second-trimester screening for Down syndrome
    Peled, Y
    Gilboa, Y
    Perri, T
    Shohat, M
    Chen, R
    Bar, J
    Hod, M
    Pardo, J
    PRENATAL DIAGNOSIS, 2003, 23 (11) : 888 - 890
  • [38] The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome
    Kadir, RA
    Economides, DL
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 9 (04) : 244 - 247
  • [39] Comparing three screening strategies for combining firstand second-trimester Down syndrome markers
    Skotko, Brian
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (05): : 1170 - 1170